PART I - AI ECHO APPLICATIONS IN CARDIAC SCREENING (VASC-123)

Disclosure(s):

Sonia Anand, MD, PhD, FRCPc, FRSC: Bayer AG: Speaker/Honoraria (Ongoing); Daiichi Sankyo: Speaker/Honoraria (Ongoing); Janssen Inc.: Speaker/Honoraria (Ongoing); Servier: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Chi-Ming Chow, MDCM MSc FRCPC FCCS: USquareSoft Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Su Ping Carolyn Lam: Alleviant Medical: Consultant/Advisory Board (Ongoing); Allysta Pharma: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); AnaCardio AB: Consultant/Advisory Board (Ongoing); Applied Therapeutics: Consultant/Advisory Board (Ongoing); Astra Zeneca: Consultant/Advisory Board (Ongoing); Bayer: Consultant/Advisory Board (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing); Bristol Myers Squibb: Consultant/Advisory Board (Ongoing); CardioRenal: Consultant/Advisory Board (Ongoing); Cytokinetics: Consultant/Advisory Board (Ongoing); Darma Inc: Consultant/Advisory Board (Ongoing); EchoNous Inc: Consultant/Advisory Board (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing); Impulse Dynamics: Consultant/Advisory Board (Ongoing); Intellia Therapeutics: Consultant/Advisory Board (Ongoing); Ionis Phamaceuticals: Consultant/Advisory Board (Ongoing); Janssen Research & Development: Consultant/Advisory Board (Ongoing); Medscape/WebMD Global: Speaker/Honoraria (Ongoing); Merck: Consultant/Advisory Board (Ongoing); Novartis: Consultant/Advisory Board (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Prosciento Inc: Consultant/Advisory Board (Ongoing); Quidel Corp: Consultant/Advisory Board (Ongoing); Radcliffe Group: Speaker/Honoraria (Ongoing); Recardio Inc: Consultant/Advisory Board (Ongoing); Roche Diagnostics: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing); Siemens Healthcare Diagnostics: Consultant/Advisory Board (Ongoing); Us2.ai: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)